Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
daniele.pastori@uniroma1.it
Daniele Pastori
Professore Associato
Struttura:
DIPARTIMENTO DI SCIENZE CLINICHE INTERNISTICHE, ANESTESIOLOGICHE E CARDIOVASCOLARI
E-mail:
daniele.pastori@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
How to treat patients with splanchnic vein thrombosis: recent advances
POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ
2023
C-reactive protein levels are associated with early cardiac complications or death in patients with acute ischemic stroke: a propensity-matched analysis of a global federated health from the TriNetX network
INTERNAL AND EMERGENCY MEDICINE
2023
Poststroke Cardiovascular Management: Current Concepts, Integrated Care, and Future Developments
CURRENT PROBLEMS IN CARDIOLOGY
2023
Association of proprotein convertase subtilisin/kexin type 9 (PCSK9) levels with abnormally high ankle-brachial index in atrial fibrillation
KARDIOLOGIA POLSKA
2023
Medium-term and long-term renal function changes with direct oral anticoagulants in elderly patients with atrial fibrillation
FRONTIERS IN PHARMACOLOGY
2023
Validating the predictive ability of the 2MACE score for major adverse cardiovascular events in patients with atrial fibrillation: results from phase II/III of the GLORIA-AF registry
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
2023
Aging and Antithrombotic Treatment
ANTIOXIDANTS & REDOX SIGNALING
2023
Renin‐angiotensin-aldosterone system inhibitors and mortality risk in elderly patients with atrial fibrillation. Insights from the nationwide START registry
EUROPEAN JOURNAL OF INTERNAL MEDICINE
2023
Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study
THROMBOSIS RESEARCH
2023
Risk of venous thromboembolism in autoimmune diseases: A comprehensive review
AUTOIMMUNITY REVIEWS
2023
Statins under-treatment and mortality in patients with atrial fibrillation. Insights from the nationwide START registry
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2023
Effect of digoxin on all-cause and cardiovascular mortality in patients with atrial fibrillation with and without heart failure: an umbrella review of systematic reviews and 12 meta-analyses
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
2023
Factor V Leiden, prothrombin, MTHFR, and PAI-1 gene polymorphisms in patients with arterial disease: A comprehensive systematic-review and meta-analysis
THROMBOSIS RESEARCH
2023
Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis
JOURNAL OF THROMBOSIS AND HAEMOSTASIS
2023
Gut barrier dysfunction and endotoxemia in heart failure: A dangerous connubium?
AMERICAN HEART JOURNAL
2023
Venous Thromboembolism in Patients With Atrial Fibrillation: A Systematic Review and Meta-Analysis of 4,170,027 Patients
2023
Adherence to the 'atrial fibrillation better care' pathway in patients with atrial fibrillation. impact on clinical outcomes-a systematic review and meta-analysis of 285,000 patients
THROMBOSIS AND HAEMOSTASIS
2022
Statin liver safety in non-alcoholic fatty liver disease: a systematic review and metanalysis
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
2022
Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study
THROMBOSIS RESEARCH
2022
Plasma homocysteine in Behcet's disease: a systematic review and meta-analysis
THROMBOSIS AND HAEMOSTASIS
2022
« prima
< precedente
1
2
3
4
5
6
7
8
9
10
11
12
seguente ›
ultima »
ERC
LS4
LS4_10
LS7
LS7_10
Keywords
cardiovascular disease
anticoagulation
Novel oral anticoagulants
atrial fibrillation
atherosclerosis
NAFLD
NASH
antiphospholipid antibody syndrome
ischemic heart disease
cardiovascular risk
Thrombosis
Atherothrombosis
Progetti di Ricerca
Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma